Status:
NOT_YET_RECRUITING
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Short Bowel Syndrome
Intestinal Failure
Eligibility:
All Genders
18+ years
Brief Summary
Home Parenteral Support (HPS) is a life-sustaining treatment for patients with short bowel syndrome and intestinal failure. This study aims to investigate how administration of parenteral support affe...
Detailed Description
The objective of this study is to investigate the applicability and accuracy of FibroScan in assessing liver status among patients with short bowel syndrome and intestinal failure, both before and aft...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years) with short bowel syndrome with capacity to give consent
- Patients receiving regular PS (≥4 days/week and ≥10 liters/week)
- Stable clinical condition
Exclusion
- Known liver cirrhosis
- Active infection, severe dehydration, or electrolyte disturbances
- Pregnancy
- Receiving IV fluids or medications on study day
- Tapered infusion rate prior to disconnection
Key Trial Info
Start Date :
February 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07206004
Start Date
February 1 2026
End Date
August 1 2027
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Digestive Diseases, Transplantation and General Surgery, Rigshospitalet
Copenhagen, Capital Region, Denmark, 2100